Bought
Maintained
Sold
Other funds holding ABBV
Sprott's ABBV Position: Q3 2026 in Review
Sprott increased its AbbVie (ABBV) stake by 0.45% in Q3 2026, buying an estimated $8.97K and bringing the position to 7,782 shares worth $2.04M. The position accounts for 0.06% of the portfolio, ranked #110.
Sprott first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Sprott held 7,782 shares of AbbVie worth $2.04M as of Q3 2026.
- Sprott bought 35 AbbVie shares in Q3 2026, an estimated $8.97K.
- AbbVie made up 0.06% of Sprott's portfolio in Q3 2026, its #110 holding.
- Sprott first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
- 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Sprott's 13F filing for Q3 2026, filed 9 Nov 2026.